EGFR expression: Associations with outcome and clinicopathological variables in malignant pleural mesothelioma

October 20, 2006 | Comments Off on EGFR expression: Associations with outcome and clinicopathological variables in malignant pleural mesothelioma

Lung Cancer, Volume 54, Issue 3, Pages 399-407 J.G. Edwardsa,b, D.E.B. Swinsona, J.L. Jonesc, D.A. Wallerb, K.J. O’Byrned a Department of Oncology, University of Leicester, Leicester, United Kingdom b Department…

Sex difference in diffuse malignant peritoneal mesothelioma

October 19, 2006 | Comments Off on Sex difference in diffuse malignant peritoneal mesothelioma

British Journal of Surgery. 2006 Oct 18; [Epub ahead of print] [Link] Yan TD, Popa E, Brun EA, Cerruto CA, Sugarbaker PH. Washington Cancer Institute, Washington, DC, USA. Abstract Background:…

Distinguishing benign mesothelial hyperplasia from neoplasia: a practical approach

October 17, 2006 | Comments Off on Distinguishing benign mesothelial hyperplasia from neoplasia: a practical approach

Seminars in Diagnostic Pathology. 2006 Feb;23(1):4-14. [Link] Kradin RL, Mark EJ. Department of Pathology, Massachusetts General Hospital, Boston, MA 02114, USA. rkradin@partners.org Abstract This paper examines the spectrum of challenges…

The role of immunohistochemistry in distinguishing squamous cell carcinoma from mesothelioma and adenocarcinoma in pleural effusion

October 17, 2006 | Comments Off on The role of immunohistochemistry in distinguishing squamous cell carcinoma from mesothelioma and adenocarcinoma in pleural effusion

Seminars in Diagnostic Pathology. 2006 Feb;23(1):15-9. [Link] Li Q, Bavikatty N, Michael CW. Department of Pathology, University of Michigan, Ann Arbor, MI 48109, USA. Abstract Background: Distinguishing metastatic squamous cell…

Pathological recognition of diffuse malignant mesothelioma of the pleura: the significance of the historical perspective as regards this signal tumor

October 17, 2006 | Comments Off on Pathological recognition of diffuse malignant mesothelioma of the pleura: the significance of the historical perspective as regards this signal tumor

Seminars in Diagnostic Pathology. 2006 Feb;23(1):25-34. [Link] Mark EJ, Kradin RL. Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston 02114, USA. Mark@helix.mgh.harvard.edu Abstract Diffuse malignant mesothelioma (DMM)…

The biological differences between ovarian serous carcinoma and diffuse peritoneal malignant mesothelioma

October 17, 2006 | Comments Off on The biological differences between ovarian serous carcinoma and diffuse peritoneal malignant mesothelioma

Seminars in Diagnostic Pathology. 2006 Feb;23(1):35-43. [Link] Davidson B, Risberg B, Berner A, Bedrossian CW, Reich R. Department of Pathology, Norwegian Radium Hospital-National Hospital, University of Oslo, Oslo, Norway. ben.davidson@radiumhospitalet.no…

Spindle cell tumors of the pleura: differential diagnosis

October 17, 2006 | Comments Off on Spindle cell tumors of the pleura: differential diagnosis

Seminars in Diagnostic Pathology. 2006 Feb;23(1):44-55. [Link] Rdzanek M, Fresco R, Pass HI, Carbone M. Thoracic Oncology Program, Cardinal Bernardin Cancer Center, Loyola University, Maywood, Illinois, USA. Abstract Spindle cell…

The pathogenesis of mesothelioma

October 17, 2006 | Comments Off on The pathogenesis of mesothelioma

Seminars in Diagnostic Pathology. 2006 Feb;23(1):56-60. [Link] Carbone M, Bedrossian CW. Thoracic Oncology Program, Cancer Research Center of Hawaii, University of Hawaii, Honolulu, Hawaii 96813, USA. mcarbone@crch.hawaii.edu Abstract Widespread asbestos…

Molecular tumor markers for asbestos-related mesothelioma: Serum diagnostic markers

October 17, 2006 | Comments Off on Molecular tumor markers for asbestos-related mesothelioma: Serum diagnostic markers

Pathology International. 2006 Nov;56(11):649-54. [Link] Maeda M, Hino O. Immuno-Biological Laboratories, Fujioka, Gunma, Japan. Abstract Mesothelioma is an aggressive tumor arising from the mesothelium, and is usually associated with previous…

The effect of a novel transition state inhibitor of methylthioadenosine phosphorylase on pemetrexed activity

October 17, 2006 | Comments Off on The effect of a novel transition state inhibitor of methylthioadenosine phosphorylase on pemetrexed activity

Molecular Cancer Therapy. 2006 Oct;5(10):2549-55. [Link] Chattopadhyay S, Zhao R, Tsai E, Schramm VL, Goldman ID. Department of Medicine and Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, New York…

Categories